Q3 2021 Holdings
Filed 2021-11-15 | 80 holdings | $26.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $6.3M | 175,000 | 23.7% |
| Atricure Inc(ATRC) | COM | 04963C209 | $5.0M | 72,029 | 19.0% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $4.3M | 123,700 | 16.3% |
| Accuray Inc(ARAY) | COM | 004397105 | $3.7M | 941,800 | 14.1% |
| Alector Inc(ALEC) | COM | 014442107 | $2.5M | 107,412 | 9.3% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $2.0M | 80,000 | 7.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $1.9M | 223,554 | 7.1% |
| Annexon Inc(ANNX) | COM | 03589W102 | $434.0K | 23,296 | 1.6% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $73.6K | 13,680,554 | 0.3% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $21.3K | 206,911 | 0.1% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $20.4K | 344,360 | 0.1% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $12.2K | 88,100 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $11.8K | 587,456 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $11.7K | 460,061 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $11.6K | 21,138 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $10.3K | 181,467 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $9.2K | 306,320 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $9.1K | 74,585 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $8.1K | 84,655 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $8.0K | 180,306 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $7.1K | 119,615 | 0.0% |
| Ishares TR Nasdaq Biotech(IBB) | ETF | 464287556 | $6.6K | 40,900 | 0.0% |
| Cardiovascular SYS Inc(CSIIEUR) | COM | 141619106 | $6.4K | 193,741 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $6.2K | 406,535 | 0.0% |
| Affimed N V | COM | N01045108 | $6.0K | 964,857 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $5.8K | 209,731 | 0.0% |
| F-Star Therapeutics Inc | COM | 30315R107 | $5.1K | 693,785 | 0.0% |
| Otonomy Inc | COM | 68906L105 | $4.6K | 2,379,392 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $4.1K | 77,675 | 0.0% |
| Radius Health Inc | NOTE 3.000% 9/0 | 750469AA6 | $3.6K | $4,000,000 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $3.5K | 216,351 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $3.3K | 189,163 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $3.3K | 289,040 | 0.0% |
| FS Development Corp II | COM CL A | 30318F100 | $3.0K | 299,950 | 0.0% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $3.0K | 376,281 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $2.9K | 809,000 | 0.0% |
| Merus N V | COM | N5749R100 | $2.9K | 131,949 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $2.8K | 447,400 | 0.0% |
| Venus Concept Inc | COM | 92332W105 | $2.8K | 1,113,228 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $2.8K | 41,952 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $2.7K | 314,561 | 0.0% |
| Mereo Biopharma Group PLC(MREO) | ADS | 589492107 | $2.7K | 1,126,613 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $2.5K | 126,652 | 0.0% |
| Proqr Therapeutics N V | SHS EURO | N71542109 | $2.5K | 296,383 | 0.0% |
| Kinnate Biopharma Inc | COM | 49705R105 | $2.5K | 106,453 | 0.0% |
| Natus MED Inc | COM | 639050103 | $2.4K | 95,653 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $2.2K | 83,061 | 0.0% |
| Neuronetics Inc(STIM) | COM | 64131A105 | $2.1K | 313,717 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $1.9K | 524,286 | 0.0% |
| Hookipa Pharma Inc | COM | 43906K100 | $1.9K | 322,124 | 0.0% |